Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Medtech

 

Alcon fails to get enough STAAR Surgical shareholders to agree to takeover

Implantable lenses maker STAAR Surgical and Alcon, the world’s largest ophtha device manufacturer, have terminated the merger agreement between them after STAAR failed to get enough of its shareholders to agree to sell. This means STAAR will not be bought out by Alcon and will continue to trade on the NASDAQ stock exchange as its own company.
January 7, 2026

UK care sector draws strong interest from global private equity

2025 was a busy year for the care sector, with lots of M&A deals either happening, planned, or being considered. Activity has risen sharply and the market is currently at a high point. HBI spoke with Amar Shah, Partner, and Vikas Sharma, Director, both in Healthcare and Life Sciences M&A at Deloitte UK, about trends in the UK social care market, including investment flows, valuations, staffing, technology and expectations for 2026.
December 11, 2025

Bridgepoint eyes takeover of AMS, maker of surgical products

London-based private-equity firm Bridgepoint is reportedly considering a takeover of UK-listed Advanced Medical Solutions (AMS), which makes surgical products such as adhesives, sutures, haemostats, and internal sealants under brands LiquiBand and RESORBA. HBI reached out to both Bridgepoint and AMS. Both companies declined to comment although neither denied the reports.
December 11, 2025

Growth equity investors are driving recovery in European healthcare M&A 

The private equity sector has faced a difficult environment for dealmaking over the past two and a half years, due to higher interest rates, regulatory uncertainty and global political pressures. This has led to a slowdown in M&A deal activity in healthcare, as well as other sectors. There are now signs of recovery. Europe is attracting more interest from global investors, especially those seeking high-quality assets with strong growth potential.
December 4, 2025

Inflexion-backed CNX Therapeutics expands specialty pharma platform

CNX Therapeutics, a European specialty pharmaceutical company, has acquired the global rights to Sativex (nabiximols), an oral spray used to treat muscle stiffness and spasms in adults with multiple sclerosis, from Jazz Pharmaceuticals, a US-based biopharmaceutical company focused on oncology and neuroscience. Guy Clark, CEO of CNX Therapeutics, tells HBI the deal strengthens the company’s […]
November 6, 2025

Canary Care launches second iteration of activity monitoring system

UK-based scale-up Canary Care has released the second iteration of its intelligent activity monitoring system. Ian Burgess, the company’s Managing Director, tells us this will be the first product of this type that can integrate with energy appliances such as smart meters, and will help care providers and health researchers to improve care with the data it collects.
October 6, 2025

Evernow and Oura Ring partner to provide personalised menopause care

Investor interest is surging in women’s health tech, with wearables like Oura Ring and Whoop attracting hundreds of millions in funding. These devices give personalised insights into menstrual, reproductive, and menopausal health, highlighting a rapidly expanding market long overlooked by traditional healthcare.
August 20, 2025
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us